PubRank

Alain Taieb

Author PubWeight™ 28.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol 2010 1.61
2 Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol 2011 1.48
3 SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol 2005 1.41
4 Treatment of generalized vitiligo with anti-TNF-α Agents. J Drugs Dermatol 2012 1.08
5 Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest 2012 1.00
6 In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res 2006 0.95
7 Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell Melanoma Res 2008 0.95
8 A novel mutation in the fatty acid transport protein 4 gene in a patient initially described as affected by self-healing congenital verruciform hyperkeratosis. Am J Med Genet A 2010 0.91
9 Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. Pigment Cell Melanoma Res 2015 0.89
10 Functional skin adaptation in infancy - almost complete but not fully competent. Exp Dermatol 2010 0.88
11 Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient. Exp Dermatol 2014 0.87
12 [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. Ann Med Interne (Paris) 2002 0.87
13 Type I interferon signature in the initiation of the immune response in vitiligo. Pigment Cell Melanoma Res 2014 0.86
14 The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype. Medicine (Baltimore) 2014 0.85
15 Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol 2013 0.84
16 Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res 2012 0.84
17 Age-related differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. J Invest Dermatol 2007 0.84
18 Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res 2011 0.83
19 Hematoma-like metastases. J Am Acad Dermatol 2006 0.83
20 In vitro research on vitiligo: strategies, principles, methodological options and common pitfalls. Exp Dermatol 2012 0.80
21 Cole Disease Results from Mutations in ENPP1. Am J Hum Genet 2013 0.80
22 Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin. Exp Dermatol 2012 0.80
23 High resolution mapping of OCA2 intragenic rearrangements and identification of a founder effect associated with a deletion in Polish albino patients. Hum Genet 2010 0.80
24 Cutaneous hyphomycosis due to Paecilomyces lilacinus. Acta Derm Venereol 2012 0.80
25 Neoadjuvant polychemotherapy in locally advanced Merkel cell carcinoma. Nat Rev Clin Oncol 2009 0.79
26 Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res 2013 0.79
27 Detection of an intragenic deletion expands the spectrum of CTSC mutations in Papillon-Lefèvre syndrome. J Invest Dermatol 2007 0.79
28 Development and validation of the K-VSCOR for scoring Koebner's phenomenon in vitiligo/non-segmental vitiligo. Pigment Cell Melanoma Res 2013 0.78
29 Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Arch Dermatol 2012 0.78
30 Assessment of tyrosinase variants and skin cancer risk in a large cohort of French subjects. J Dermatol Sci 2011 0.78
31 Recurrent superficial mucoceles associated with lichenoid disorders. J Oral Maxillofac Surg 2006 0.78
32 Mast cells as possible targets of propranolol therapy: an immunohistological study of beta-adrenergic receptors in infantile haemangiomas. Histopathology 2014 0.77
33 A case of primary erythermalgia with encephalopathy. J Neurol 2009 0.77
34 Treatment of pre-ulcerative necrobiosis lipoidica with infliximab. Acta Derm Venereol 2011 0.75
35 Merkel cell carcinoma: complete clinical remission associated with disease progression. JAMA Dermatol 2013 0.75
36 A further case of annular lichenoid dermatitis of youth: role of the anti-hepatitis B immunization? Pediatr Dermatol 2008 0.75
37 Dermatofibrosarcoma protuberans occurring in two brothers: Role of environmental or genetic factors? J Am Acad Dermatol 2007 0.75
38 Cutaneous epidermal cysts as a presentation of gorlin syndrome. Arch Dermatol 2009 0.75
39 Validation of a specific health-related quality of life instrument in a large cohort of patients with psoriasis: the QualiPso Questionnaire. Acta Derm Venereol 2011 0.75
40 Metastatic melanoma with leukaemia-like evolution. Acta Derm Venereol 2013 0.75
41 Are post-vaccinal persistent itching nodules related to the use of local anaesthetic patches? A hypothesis to be confirmed. Contact Dermatitis 2012 0.75
42 Accelerating bleaching in vitiligo: balancing benefits versus risks. Exp Dermatol 2014 0.75
43 Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases. Chem Immunol Allergy 2012 0.75
44 [Metastatic cutaneous hematoma variant from melanoma: five cases]. Bull Cancer 2011 0.75
45 Oral alitretinoin in chronic refractory hand eczema: a "real life" case-series of 12 patients. Eur J Dermatol 2011 0.75
46 An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis. Pediatr Dermatol 2014 0.75
47 Orificial tuberculosis in an immunocompetent careworker. Acta Derm Venereol 2010 0.75
48 Baboon syndrome induced by cetuximab. Arch Dermatol 2008 0.75
49 Penile swelling and ulceration. Acta Derm Venereol 2010 0.75
50 On Zimmerman's "Dermatitis factitia as a war weapon". Arch Dermatol 2003 0.75